Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen
about
Measles to the Rescue: A Review of Oncolytic Measles VirusStructural basis of efficient contagion: measles variations on a theme by parainfluenza viruses.Viral oncolysis - can insights from measles be transferred to canine distemper virus?Envelope targeting: hemagglutinin attachment specificity rather than fusion protein cleavage-activation restricts Tupaia paramyxovirus tropism.Polyploid measles virus with hexameric genome length.Ligand-directed targeting of genes to the site of disease.Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entry.Rapid adaptation of a recombinant vesicular stomatitis virus to a targeted cell lineRNA viruses as virotherapy agents.CEA-based vaccines.Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis.Attenuated oncolytic measles virus strains as cancer therapeuticsAntibody engineering: facing new challenges in cancer therapy.Triggering the measles virus membrane fusion machinery.The receptor attachment function of measles virus hemagglutinin can be replaced with an autonomous protein that binds Her2/neu while maintaining its fusion-helper function.Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.Taming the Trojan horse: optimizing dynamic carrier cell/oncolytic virus systems for cancer biotherapy.Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded.Oncolytic measles virus strains as novel anticancer agents.Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.Measles virus for cancer therapy.Targeted cell entry of lentiviral vectors.Adenoviral Vectors Armed with Cell Fusion-Inducing Proteins as Anti-Cancer Agents.Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein.Retargeting of viruses to generate oncolytic agents.Reverse genetics of Mononegavirales: How they work, new vaccines, and new cancer therapeuticsOncolytic viruses: a new class of immunotherapy drugs.Fighting Cancer with Mathematics and Viruses.Potential and clinical translation of oncolytic measles viruses.DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.Strength of envelope protein interaction modulates cytopathicity of measles virus.Importance of the cytoplasmic tails of the measles virus glycoproteins for fusogenic activity and the generation of recombinant measles viruses.A hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon.Recombinant vesicular stomatitis virus targeted to Her2/neu combined with anti-CTLA4 antibody eliminates implanted mammary tumors.Oncolytic Viral Therapy for Mesothelioma.Oncolytic measles virus encoding interleukin-12 mediates potent antitumor effects through T cell activation.Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapter.Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model.An adenovirus vector with a chimeric fiber incorporating stabilized single chain antibody achieves targeted gene delivery.Selective cytolysis of tumor cells by mumps virus S79.
P2860
Q28072097-F9DC4509-B84D-452B-8006-8E6EB82382BEQ30358662-844CD945-A2C8-4E26-A2E9-508095011F5BQ33820717-8C81229D-4365-4499-B407-08E1A14E3F1BQ33911962-CCC6F658-6D50-45F1-BC7F-9EACBDADC234Q34087644-2F802B10-A160-4429-B639-D88BAEF66927Q34168868-8034FC89-9D3C-43FB-98E5-AE5A4832EE65Q34178182-5CCAD630-4EFC-411A-A25F-CE1AD4B90051Q35024068-DC380578-6257-45A0-B415-22763BD2F0ADQ35043090-D084FE79-2A76-4670-B04D-8536E4BE286FQ35195921-B4297849-D6F3-465A-B489-EC3477B895D4Q35285887-AE48DEE4-2755-4CE2-B24D-6EB5871F42F9Q35818876-D53315E0-E4A2-41DB-A061-5C9CABACD8ECQ36139507-6D9F8A33-001B-4119-B46E-F3B72517DE7AQ36397970-26BEB236-F057-4050-83E0-265314FC627EQ36827199-D137F1F4-2E60-4F47-A28F-4DE22D7524D7Q37035678-2B91C75E-2DB8-49BB-B156-1A27350D1929Q37120166-D214F5EF-F036-4C7F-B82A-3F6FC4B49B0CQ37191007-2AC32F49-C07E-431B-9BB0-AB22457E4055Q37261017-208ABCF3-A8BE-41C3-955C-8C17117E54A3Q37336713-0BFAD6EA-F35A-4730-BD7C-BB510246AE75Q37388577-35A43B4D-7BCD-4A3D-8BD5-94D60671CD7DQ37589994-CC654867-1A32-4EBE-A527-730EE0CFE95EQ37628219-ACFFF023-C014-44E8-A2CD-9026F012524FQ37730395-1B199B22-52F5-4DFD-8277-0CFB0111477EQ37982062-1B350113-A175-40B4-A9D3-1E964A09D078Q38363535-719ED3A3-2F59-4B7A-B8C8-A03FD1FF0FA5Q38577450-A28C7688-8AC7-45AE-BC2D-B8AE6369649DQ38612646-6EBCD62E-EEE6-4E68-AE96-751FBB5FA10FQ38764947-95F6072A-0FD0-4D54-BE42-15C1CD29B11AQ39199726-FAB120FA-EA5B-4525-BCC5-1B7F42ED9824Q39683453-B7C75925-9215-4808-846A-60F6F7E6DDE6Q39684160-3418DE2D-A0B5-4B65-8E47-9D875962402AQ39955752-3413885D-9CFD-4D6A-BC47-196A3732227CQ39957477-305E6BB3-C451-4F5A-9394-607362A5FF2EQ40051845-43E80CB9-F393-408D-882C-D3D64A288853Q40200208-A6E42DCE-38B0-40B4-8FF0-E09628C3A505Q40329170-BE5F7EBB-AAD1-4E6A-8144-793F8F52727BQ40377179-8BEDBF90-E65B-4090-B9B7-3C72AC3A58FFQ40383912-2FCAE1A4-B42F-4CBA-B429-A7D710DD2BF2Q40409461-94AD250D-EB10-4F1E-B93B-8AEDFE844E55
P2860
Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Single-chain antibody displaye ...... iated carcinoembryonic antigen
@en
Single-chain antibody displaye ...... ated carcinoembryonic antigen.
@nl
type
label
Single-chain antibody displaye ...... iated carcinoembryonic antigen
@en
Single-chain antibody displaye ...... ated carcinoembryonic antigen.
@nl
prefLabel
Single-chain antibody displaye ...... iated carcinoembryonic antigen
@en
Single-chain antibody displaye ...... ated carcinoembryonic antigen.
@nl
P2093
P2860
P1433
P1476
Single-chain antibody displaye ...... iated carcinoembryonic antigen
@en
P2093
P2860
P304
P356
10.1128/JVI.75.5.2087-2096.2001
P407
P577
2001-03-01T00:00:00Z